DPLO - Diplomat to Participate in 37th Annual J.P. Morgan Healthcare Conference

FLINT, Mich., Dec. 19, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), executives will present at this year's J.P. Morgan Healthcare Conference in San Francisco.

Diplomat's Brian Griffin, chairman and CEO, and Atul Kavthekar, chief financial officer, are scheduled to present at 8 a.m. PT Monday, Jan. 7. Joel Saban, president, will also attend the conference.

A live audio webcast of the presentation and related presentation materials will be available on the investor relations section of Diplomat's website at ir.diplomat.is. An audio recording and related presentation materials will be available online for approximately 90 days.

To learn more about Diplomat, visit diplomat.is.

About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues – always focused on improving patient care. For more information, visit diplomat.is.

CONTACT:
Terri Anne Powers, Vice President of Investor Relations
312.889.5244 | tpowers@diplomat.is

Elizabeth Carr, Corporate Communications Manager
810.768.9871 | press@diplomat.is

View original content to download multimedia:http://www.prnewswire.com/news-releases/diplomat-to-participate-in-37th-annual-jp-morgan-healthcare-conference-300768818.html

SOURCE Diplomat Pharmacy, Inc.